This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Alexandria (ARE) Recapitalizes San Diego Property at $981/RSF
by Zacks Equity Research
In sync with its capital-recycling strategy, Alexandria (ARE) and its JV partner divest 70% interest in 9625 Towne Centre Drive, fully leased to Takeda, in San Diego's UTC submarket at $981 per RSF.
Alexandria (ARE) Divests 5 Non-Core Properties for $365M
by Zacks Equity Research
Keeping up with its capital-recycling strategy, Alexandria (ARE) announces the disposition of five non-core assets in Greater Boston, spanning 428,663 rentable square feet, for $365 million.
Alexandria (ARE) Rewards Investors, Hikes Dividend by 2.5%
by Zacks Equity Research
Alexandria (ARE) boosts investors' confidence with a dividend hike of 2.5%. Robust operating results, a decent financial position and a lower payout ratio make the dividend rate sustainable.
Alexandria (ARE) Boosts Asset Recycling Strategy With $86M Sale
by Zacks Equity Research
Capitalizing on robust market valuations, Alexandria (ARE) propels its asset recycling strategy, selling a San Diego cluster property for $86 million.
Welltower (WELL) Q1 FFO Tops, SHO Occupancy Up, '23 View Raised
by Zacks Equity Research
Welltower's (WELL) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company raises its 2023 FFO per share outlook.
This is Why Alexandria Real Estate Equities (ARE) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Digital Realty (DLR) Q1 FFO Beats, Revenues Increase Y/Y
by Zacks Equity Research
Digital Realty's (DLR) Q1 performance reflects year-over-year growth in the top line. However, rising operating expenses act as a spoilsport.
Healthpeak's (PEAK) Q1 FFO Meets Estimates, Revenues Beat
by Zacks Equity Research
Healthpeak's (PEAK) Q1 performance reflects year-over-year growth in revenues. Same-store portfolio cash (adjusted) net operating income improves year over year.
Highwoods (HIW) Q1 FFO Beats Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Highwoods' (HIW) Q1 results reflect a year-over-year increase in the top line on rent growth. However, a fall in occupancy and higher operating expenses act as dampeners.
American Tower (AMT) Q1 AFFO & Revenues Top, '23 View Revised
by Zacks Equity Research
American Tower's (AMT) Q1 earnings beat estimates on better-than-anticipated revenues and strong organic tenant billing growth. It revises its outlook for 2023.
Boston Properties (BXP) Q1 FFO & Revenues Top, '23 View Up
by Zacks Equity Research
Boston Properties' (BXP) Q1 results outshine estimates on better-than-anticipated revenues, aided by healthy leasing activity. It raises its 2023 guidance for FFO per share.
Alexandria (ARE) Q1 FFO Tops on Rent Growth, '23 View Revised
by Zacks Equity Research
Alexandria Real Estate's (ARE) Q1 results outshine estimates on healthy leasing activity and solid rental rate growth. It narrows its 2023 adjusted FFO per share outlook.
Alexandria Real Estate Equities (ARE) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) delivered FFO and revenue surprises of 1.86% and 3.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Crown Castle's (CCI) Q1 AFFO Lags Estimates, Revenues Up Y/Y
by Zacks Equity Research
Amid elevated tower space demand for 5G deployment, Crown Castle's (CCI) top line improves year over year on healthy site-rental revenue growth. It maintains its 2023 outlook.
SL Green's (SLG) FFO and Revenues Surpass Estimates in Q1
by Zacks Equity Research
SL Green's (SLG) Q1 earnings outshine estimates on better-than-anticipated revenues. However, the occupancy in the company's Manhattan same-store office portfolio falls year over year.
Prologis (PLD) Beats Q1 FFO Estimates on Solid Rent Growth
by Zacks Equity Research
Prologis (PLD) puts up a decent show in the first quarter on robust activity and rent growth.
What's in Store for Alexandria (ARE) This Earnings Season?
by Zacks Equity Research
Robust demand for high-quality life science and lab office properties in key markets, creditworthy tenants and adequate financial flexibility are likely to have aided Alexandria's (ARE) Q1 earnings.
Alexandria (ARE) Transfers Partial Interest in 15 Necco Street
by Zacks Equity Research
Amid the solid demand for high-quality life science assets, Alexandria (ARE) closes the strategic partial interest transaction for 15 Necco Street to a U.S. affiliate of Mori Trust Co., Ltd.
Alexandria Real Estate Equities (ARE) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Here's Why You Should Retain Alexandria (ARE) Stock for Now
by Zacks Equity Research
Solid demand for high-quality life science and lab office properties in key markets and strategic buyouts bode well for Alexandria (ARE). However, interest rate hikes are a key concern.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Should Investors Retain OUTFRONT Media (OUT) Stock for Now?
by Zacks Equity Research
OUTFRONT Media's (OUT) diversified advertising sites and strategic investments for digital-billboard conversions bode well. However, stiff competition and rising interest rates are worrisome.
Medical Properties (MPW) to Dispose of Healthscope Portfolio
by Zacks Equity Research
Medical Properties (MPW) enters an agreement with affiliates of HMC Capital to dispose of its Healthscope portfolio. The move is in line with its capital recycling strategy.
Is it Wise to Retain Equity Residential (EQR) Stock for Now?
by Zacks Equity Research
Healthy demand for residential properties, expansionary efforts and technological innovations bode well for Equity Residential (EQR). The lack of rent relief and interest rate hikes are worrisome.
Four Corners (FCPT) on Buying Spree, Acquires Indiana Asset
by Zacks Equity Research
To strengthen its portfolio with real estate leased to strong credit operators, Four Corners (FCPT) announces the acquisition of a WellNow Urgent Care property in Indiana for $2.5 million.